Log in
Forgot password ?
Become a member for free
Sign up
Sign up
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nasdaq  >  Gilead Sciences    GILD

Mes dernières consult.
Most popular
Business Summary
Logo Gilead Sciences
Discovers, develops and commercializes therapeutic products and treatments for life threatening diseases

Gilead Sciences, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of medicines in areas of unmet medical need.

The firm offers antiviral products under Harvoni, Genvoya, Epclusa, Truvada, Atripla, Descovy, Stribild, Viread, Odefsey, Complera/Eviplera, Sovaldi, and Vosevi brands.

It also offers other pharmaceutical products under the Letairis, Ranexa, AmBisome, and Zydelig brands.

The company was founded by Michael L. Riordan on June 22, 1987 and is headquartered in Foster City, CA.

Number of employees : 10 000 persons.
Sales per Businesses
USD (in Million)%USD (in Million)%
Innovative Medicines30,390100.2%26,10799.9% -14.09%
Sales per Regions
USD (in Million)%USD (in Million)%
United States19,35463.8%18,19469.6% -5.99%
Europe6,36521%5,31120.3% -16.56%
Other Countries2,1447.1%2,60210% +21.36%
John Milligan571990President, Chief Executive Officer & Director
John Martin661990Chairman
Robin L. Washington MBA, CPA552008CFO, Principal Accounting Officer & Executive VP
Andrew Cheng MD, PhD-1999Chief Medical Officer & Executive Vice President
John G. McHutchison, MD-2010Chief Scientific Officer
George Pratt Shultz, PhD951996Director-Emeritus
Gayle Edlund Wilson752001Independent Director
John Francis Cogan, PhD702005Lead Independent Director
Richard J. Whitley, MD722008Independent Director
Kevin E. Lofton632009Independent Director
Vote QuantityFloatCompany-owned sharesTotal Float
Share A 1 1,300,260,832 1,291,636,561 99.3% 0 0.0% 99.3%
The Vanguard Group, Inc. 92,988,748 7.15%
BlackRock Fund Advisors 70,032,565 5.39%
SSgA Funds Management, Inc. 53,913,342 4.15%
Capital Research & Management Co. (Global Investors) 42,943,339 3.30%
Fidelity Management & Research Co. 23,189,439 1.78%
Parnassus Investments 19,710,860 1.52%
T. Rowe Price Associates, Inc. 17,419,309 1.34%
Geode Capital Management LLC 17,027,568 1.31%
Northern Trust Investments, Inc. 16,497,946 1.27%
Dodge & Cox 15,445,461 1.19%
Galapagos (GLPG) 6,760,70113.2%623,109,473 USD
Markets and indexes
- Nasdaq Stock Market
- Nasdaq Global Select Market
- Nasdaq 100 / SP 100, SP 500, Stoxx Americas 100, Stoxx Global 200, Stoxx NorthAmerica 50, Stoxx USA 50
Stock Exchange Codes
- Bloomberg Code :  GILD:US
- Reuters Code :  GILD.O
- Datastream Code :  @GILD
Company contact information
Gilead Sciences
333 Lakeside Drive
CA 94404 San Mateo, California
États-Unis (les)

Phone : +1 650 574 3000
Fax : +1 650 578 9264
Internet : http://www.gilead.com
Connections : Gilead Sciences
Charles Schwab Family of Funds
Kite Pharma, Inc.
University of Southern California
Primus Pharmaceuticals, Inc.
American Society of Clinical Investigation
Venture Lending & Leasing II, Inc.
Ohio Wesleyan University
Stanford University
Biotechnology Innovation Organization
The University of Alabama at Birmingham
Children's Discovery Museum
Catholic Health Initiatives
Gilead Connecticut, Inc.
UCSF Benioff Children's Hospital Oakland
ISI Life Sciences, Inc.
Syntimmune, Inc.
Venture Lending & Leasing, Inc.
Global Virus Network
Sacred Heart Schools Atherton
Oxford BioTherapeutics Ltd.
FermaVir Pharmaceuticals, Inc.
The Royal Australasian College of Physicians
Alabama Drug Discovery Alliance
Acuitus, Inc.
Washington University School of Medicine
Ralph M. Parsons Foundation
Association of American Physicians
Morehouse School of Medicine
Catholic Health Association of the USA
California Institute of Technology
Jet Propulsion Laboratory
Conifer Health Solutions LLC
Official Publications
© 2018 People , Fundamentals and Ownership
© 2018 Cofisem